TANGAN IBU MEDIS reflects our belief that healthcare should be as comforting and reassuring as a mother’s gentle touch. We are committed to being a trusted partner for both patients and healthcare professionals by delivering high-quality medical devices that enhance clinical outcomes and improve patient care.
Founded in 2019, our company has grown through providing import and export agency services in Indonesia for medical devices, cosmetic ingredients, and beauty products. Since 2025, we have been focusing on our medical device business and have been expanding it through the establishment and operation of PT Tangan Ibu Medis (PT TIM), a specialized medical device distribution company.
We hold the exclusive distribution rights in Indonesia for the following FDA-certified medical devices:
In addition to supplying medical devices, we provide end-to-end support services, including installation, user training, technical assistance, and after-sales support to ensure optimal performance and long-term reliability.
In November 2025, PT Tangan Ibu Medis signed a 10-year joint operation agreement with RSJPD Harapan Kita, Indonesia’s National Cardiovascular Center in West Jakarta, to establish a dedicated HiCardi+ H100 Holter Interpretation Center serving patients across Indonesia, including BPJS beneficiaries.
VisionTo be the innovative Indonesian Foreign Investment Corporation that distributes and manufactures cutting-edge medical devices in Indonesia.
We grow by applying new ideas and methods to your business and work.
We analyze the market quickly and execute strategies to dominate the market.
We grow together with our customers, partners, and the local community through consideration and communication.
We take responsibility for our decisions, actions, and outcomes.
A wearable wireless Holter monitor that overcomes the limitations of conventional wired Holter devices and records continuous ECG data for up to 72 hours. Applicable for Holter monitoring and for patients with confirmed or suspected arrhythmia.
A digital cardiac monitoring platform that measures, transmits, and monitors patient vital signals in real time — usable not only for inpatient monitoring but also for post-discharge home care.
General wards, cardiac rehabilitation centers, post-PCI/CABG patients, dialysis units, chemotherapy units, real-time ambulance monitoring, and home remote monitoring (telehealth capable).
A lightweight mobile X-ray system equipped with a high-performance digital detector and built-in PC. Manufactured by LIVERMORETECH INC, USA.
Mobile imaging within hospitals, ambulances, home visits, remote healthcare settings, and large-scale screening programs. Participating in mobile screening projects aligned with the Indonesian government's initiative to expand early tuberculosis (TB) detection.
All products hold valid Indonesian regulatory approvals (AKL).
Compact adhesive chest patch recording ECG for up to 72 hours. IP67 waterproof, wireless, FDA-approved Holter monitor.
Digital cardiac monitoring platform measuring and transmitting ECG, heart rate, respiration, and body temperature in real time via smartphone.
Lightweight mobile X-ray with built-in PC and 10.1" touch screen. Wirelessly transmits images; used in Indonesia TB mobile screening programs.
All products and operations hold valid Indonesian regulatory permits, ensuring full compliance with national healthcare standards.

Indonesian Medical Device Registration — HiCardi+ H100

Indonesian Medical Device Registration — HiCardi+

AiRTouch 905 Portable X-Ray — authorized distributor

With RSJPD Harapan Kita regarding the use of HiCardi+ H100

Medical Device Distribution License — AiRTouch 905 Portable X-Ray

Justification of Radiation Usage — AiRTouch 905 Portable X-Ray
Participated as an exhibitor at IICS 2024, connecting with Indonesia's leading cardiovascular healthcare professionals and industry stakeholders.
Participated in the Jakarta Medical Devices Exhibition, strengthening industry networks and gaining insights into the latest developments in Indonesia's medical device sector.
Official visit by the President Director and Key Executives of RSJPD Harapan Kita to MEZOO Co., LTD headquarters and leading cardiovascular medical institutions in South Korea, including Severance Hospital, Wonju Severance Christian Hospital, and Samsung Medical Center (2025).
Signed a 10-year Joint Operation Agreement with RSJPD Harapan Kita, Indonesia’s National Cardiovascular Center, to establish a dedicated HiCardi+ H100 Holter Interpretation Center.
Mr. Andi
VR 6 Victoria Square Jl. Gatot Subroto Km. 3 No. 78 Cimone, Tangerang
Banten 15114, Indonesia
RSJPD Harapan Kita
Gedung Perawatan 2, Lantai 7
Jl. Letjen S. Parman Kav. 87, Slipi
Jakarta 11420, Indonesia